Sections
Edition
Language
Economy
Pharmaceuticals

Almirall raises its profits by 49.4% in the first half of 2026 to 39.6 million

Unverified translation
The facade of the headquarters of the Catalan pharmaceutical company Almirall on the Ronda General Mitre in Barcelona, in a file image.
The facade of the headquarters of the Catalan pharmaceutical company Almirall on Ronda General Mitre in Barcelona, in an archive image. MARC ROVIRA
24/07/2026 - 16:51 h.
1 min

Almirall closed the first half of 2026 with a net profit of 39.6 million euros, 49.4% more than in the same period of 2025, as reported this Friday to the CNMV. In this period, the pharmaceutical company increased its net sales by 7.5%, to 602.7 million.

stats